Pulse Biosciences (PLSE) Revenue & Revenue Breakdown
Pulse Biosciences Revenue Highlights
Latest Revenue (Q)
$401.00K
Main Segment (Y)
Cycle Units Products
Main Geography (Y)
North America
Pulse Biosciences Revenue by Period
Pulse Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $700.00K | -50.63% |
| 2021-12-31 | $1.42M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
Pulse Biosciences generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Pulse Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $401.00K | 51.89% |
| 2025-12-31 | $264.00K | 206.98% |
| 2025-09-30 | $86.00K | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $-9.00K | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $265.00K | -40.32% |
| 2022-03-31 | $444.00K | -47.39% |
| 2021-12-31 | $844.00K | 47.04% |
| 2021-09-30 | $574.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | - |
Pulse Biosciences generated $401.00K in revenue during Q1 2026, up 51.89% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Pulse Biosciences Revenue Breakdown
Pulse Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 |
|---|---|
| Cycle Units Products | $140.00K |
Pulse Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Cycle Units Products (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Sep 21 |
|---|---|---|
| Operating Segments | $172.00K | - |
| Systems Products | - | $490.00K |
| Cycle Units Products | - | $84.00K |
Pulse Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Operating Segments (100.00%).
Pulse Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 |
|---|---|
| Rest of World | $183.00K |
| North America | $517.00K |
Pulse Biosciences's latest annual revenue breakdown by geography, as of Dec 22: North America (73.86%), and Rest of World (26.14%).
Quarterly Revenue by Country
| Country | Sep 21 |
|---|---|
| North America | $405.00K |
| Cycle Units Products | $84.00K |
| Non Us | $169.00K |
| Systems Products | $490.00K |
Pulse Biosciences's latest quarterly revenue breakdown by geography, as of Sep 21: Systems Products (42.68%), North America (35.28%), Non Us (14.72%), and Cycle Units Products (7.32%).
Pulse Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NVCR | NovoCure | $655.35M | $174.06M |
| OPK | OPKO Health | $606.89M | $124.20M |
| STAA | STAAR Surgical | $239.44M | $93.52M |
| LFMD | LifeMD | $194.06M | $50.16M |
| BBNX | Beta Bionics | $100.25M | $27.63M |
| NKTR | Nektar Therapeutics | $55.23M | $10.86M |
| IMTX | Immatics | $54.00M | $30.45M |
| KMTS | Kestra Medical | $27.81M | $24.55M |
| DNTH | Dianthus Therapeutics | $2.04M | - |
| ATAI | Atai Beckley | - | $749.00K |
| PLSE | Pulse Biosciences | - | $401.00K |